Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,538 | 45,541 | 65,774 | 71,973 | 62,737 |
| Marketable Securities | 72,876 | 69,741 | 66,833 | 78,267 | 105,910 |
| Receivables | 6,608 | 5,747 | 5,770 | 5,536 | 6,411 |
| Inventories | 5,851 | 5,381 | 5,267 | 5,120 | 5,653 |
| TOTAL | $123,687 | $133,384 | $150,320 | $167,278 | $187,007 |
| Non-Current Assets | |||||
| PPE Net | 1,989 | 2,213 | 2,449 | 2,705 | 2,971 |
| Other Non-Current Assets | 7,389 | 8,714 | 9,389 | 10,456 | 10,253 |
| TOTAL | $9,378 | $10,927 | $11,838 | $13,161 | $13,224 |
| Total Assets | $133,065 | $144,311 | $162,158 | $180,439 | $200,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,232 | 3,232 | 2,041 | 1,739 | 1,585 |
| Accounts payable and accrued liabilities | 2,469 | 3,672 | 6,932 | 6,775 | 6,351 |
| Accrued Expenses | 13,694 | 15,044 | 16,117 | 16,007 | 16,258 |
| Other current liabilities | 1,820 | 1,830 | 1,858 | 1,837 | 1,523 |
| TOTAL | $21,215 | $23,778 | $26,948 | $26,358 | $25,717 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,300 | 126,065 | 125,674 | 124,078 | 121,943 |
| Other Non-Current Liabilities | 9,959 | 10,321 | 10,429 | 10,246 | 9,868 |
| TOTAL | $136,259 | $136,386 | $136,103 | $134,324 | $131,811 |
| Total Liabilities | $157,474 | $160,164 | $163,051 | $160,682 | $157,528 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,282 | 28,158 | 28,013 | 27,858 | 27,771 |
| Common Shares | 33 | 33 | 33 | 32 | 32 |
| Retained earnings | -475,098 | -464,532 | -447,884 | -424,809 | -397,227 |
| Other shareholders' equity | 120 | 73 | 16 | 69 | 103 |
| TOTAL | $-24,409 | $-15,853 | $-893 | $19,757 | $42,703 |
| Total Liabilities And Equity | $133,065 | $144,311 | $162,158 | $180,439 | $200,231 |